malondialdehyde has been researched along with Necrotizing Pyelonephritis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, SK; Chhibber, S; Harjai, K; Sharma, K | 1 |
| Gupta, P; Gupta, RK; Harjai, K | 1 |
| Armaganidis, A; Dimopoulos, G; Giamarellos-Bourboulis, EJ; Lignos, M; Theodorakopoulou, M; Tsaganos, T; Tzepi, IM | 1 |
| Korol, LV | 1 |
| Ashikhmina, EP; Barkova, EN; Lebedeva, KA | 1 |
| Chhibber, S; Harjai, K; Mittal, R; Sharma, S | 1 |
| Bedir, O; Caliskan, B; Cayci, T; Guven, A; Korkmaz, A; Ozcan, A; Ozler, M; Surer, I | 1 |
| Ertoy Baydar, D; Kasap, B; Kavukçu, S; Kiray, M; Soylu, A; Tuğyan, K | 1 |
| Shymonko, IT | 1 |
| Adamis, T; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Laoutaris, G; Mouktaroudi, M; Perrea, D; Sabracos, L | 1 |
| Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Koutoukas, P; Panagou, C; Perrea, D; Sabracos, L | 1 |
| Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T | 1 |
| Adamis, T; Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koutoukas, P; Panagou, C; Raftogiannis, M; Tsaganos, T; Tziortzioti, V | 1 |
| Biyikli, NK; Cetinel, S; Gedik, N; Midillioğlu, S; Sener, G; Tuğtepe, H; Velioğlu-Oğünç, A; Yeğen, BC | 1 |
| Aslantas, O; Celik, S; Erdogan, S; Gorur, S; Hakverdi, S; Ocak, S | 1 |
| Cetinel, S; Sener, G; Tuğtepe, H; Velioğlu-Oğünç, A; Yeğen, BC | 1 |
| Ganguly, NK; Gupta, R; Gupta, S | 1 |
| Gorelova, NR; Nikulina, GG; Petrun', NM; Pyrig, LA | 1 |
| Bankova, VV; Mlynchik, EV | 1 |
19 other study(ies) available for malondialdehyde and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Exploring the Therapeutic Efficacy of Zingerone Nanoparticles in Treating Biofilm-Associated Pyelonephritis Caused by Pseudomonas aeruginosa in the Murine Model.
Topics: Animals; Biofilms; Disease Models, Animal; Guaiacol; HEK293 Cells; Humans; Inflammation; Malondialdehyde; Mice; Microscopy, Electron, Scanning; Nanoparticles; Peroxidase; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Stem Cells; Tetrazolium Salts; Thiazoles | 2020 |
Quorum sensing signal molecules produced by Pseudomonas aeruginosa cause inflammation and escape host factors in murine model of urinary tract infection.
Topics: Animals; Bacterial Adhesion; Female; Inflammation; Malondialdehyde; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Quorum Sensing; Reactive Nitrogen Species; Signal Transduction; Urinary Tract; Urinary Tract Infections | 2013 |
Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunologic Factors; Male; Malondialdehyde; Propanolamines; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits | 2015 |
[MODELING IN VITRO PATHWAYS OF ACTIVATION OF LIPID PEROXIDATION AND PROTEIN IN CHRONIC KIDNEY DISEASE].
Topics: Ascorbic Acid; Case-Control Studies; Chronic Disease; Erythrocytes; Ferrous Compounds; Glomerulonephritis; Humans; Lipid Peroxidation; Malondialdehyde; Primary Cell Culture; Protein Carbonylation; Pyelonephritis | 2015 |
Erythropoiesis and iron metabolism biorhythms in children with chronic pyelonephritis.
Topics: Child; Chronic Disease; Circadian Rhythm; Erythropoiesis; Female; Humans; Iron; Malondialdehyde; Pyelonephritis | 2008 |
Evaluation of interleukin-10 production in Pseudomonas aeruginosa induced acute pyelonephritis.
Topics: Analysis of Variance; Animals; Biofilms; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Euthanasia, Animal; Humans; Interleukin-10; Kidney; Malondialdehyde; Mice; Neutrophils; Plankton; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis | 2009 |
Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Calcitonin; Ciprofloxacin; Creatine; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Fibrosis; Glutathione Peroxidase; Kidney; L-Lactate Dehydrogenase; Male; Malondialdehyde; Neopterin; Oxidative Stress; Ozone; Protein Precursors; Pyelonephritis; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Urea | 2011 |
Protective effects of bilirubin in an experimental rat model of pyelonephritis.
Topics: Animals; Antioxidants; Bilirubin; Disease Models, Animal; Female; Immunohistochemistry; In Situ Nick-End Labeling; Lipid Peroxidation; Malondialdehyde; Pyelonephritis; Rats; Rats, Wistar; Superoxide Dismutase; Tissue Inhibitor of Metalloproteinase-1 | 2012 |
[Enhancing efficiency of sanatorium treatment of patients with chronic pyelonephritis using hyperbaric oxygenation].
Topics: Adult; Balneology; Chronic Disease; Diuresis; Health Resorts; Humans; Hyperbaric Oxygenation; Kidney Function Tests; Lipid Peroxidation; Lipid Peroxides; Malondialdehyde; Middle Aged; Pyelonephritis; Superoxide Dismutase | 2002 |
Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.
Topics: Acute Disease; Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Immunity; Lipopolysaccharides; Male; Malondialdehyde; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Sepsis; Survival Analysis; Tumor Necrosis Factor-alpha | 2004 |
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Lipopolysaccharides; Malondialdehyde; Pyelonephritis; Rabbits; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Immunologic Factors; Kidney; Lipopolysaccharides; Liver; Lung; Male; Malondialdehyde; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Spleen; Tumor Necrosis Factor-alpha | 2006 |
Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism.
Topics: Animals; Antioxidants; Collagen; Creatinine; Glutathione; Kidney; Kidney Function Tests; L-Lactate Dehydrogenase; Male; Malondialdehyde; Neutrophils; Oxidative Stress; Oxytocin; Pyelonephritis; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Urea | 2006 |
Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in rats.
Topics: Animals; Caffeic Acids; Catalase; Escherichia coli; Glutathione Peroxidase; Inflammation; Kidney; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Pyelonephritis; Rats; Rats, Wistar; Superoxide Dismutase; Xanthine Oxidase | 2007 |
Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Topics: Acetates; Animals; Blood Urea Nitrogen; Creatinine; Cyclopropanes; Escherichia coli; Female; Glutathione; L-Lactate Dehydrogenase; Leukotriene Antagonists; Lipid Peroxidation; Luminescent Measurements; Male; Malondialdehyde; Membrane Proteins; Peroxidase; Pyelonephritis; Quinolines; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Leukotriene; Sulfides; Tumor Necrosis Factor-alpha | 2007 |
Role of type-1 fimbriae in the pathogenesis of chronic pyelonephritis in relation to reactive oxygen species.
Topics: Animals; Cells, Cultured; Chronic Disease; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Fimbriae, Bacterial; Kidney; Luminescent Measurements; Macrophages, Peritoneal; Malondialdehyde; Mice; Mice, Inbred BALB C; Pyelonephritis; Reactive Oxygen Species; Respiratory Burst | 1997 |
[Lipid metabolism in primary and combined lesions of the kidneys in pregnant women].
Topics: Female; Glomerulonephritis; Humans; Kidney Diseases; Lipid Metabolism; Lipids; Lipoproteins, LDL; Malondialdehyde; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pyelonephritis | 1990 |
[Characteristics of the structuro-functional state of cell membranes in children with obstructive pyelonephritis before and after surgical intervention].
Topics: Adolescent; Child; Child, Preschool; Erythrocyte Membrane; Humans; Infant; Malondialdehyde; Postoperative Period; Pyelonephritis | 1988 |